Summary
The objective of this analysis was to evaluate the socioeconomic consequences of routine administration of low molecular weight heparin (LMWH) as thromboprophylaxis in patients undergoing total hip arthroplasty, on the basis of data from a number of clinical studies. Despite the higher direct costs associated with LMWH, this regimen was more cost effective per thromboembolic complication prevented than no prophylaxis, dextran 70, or low dose un-fractionated heparin. A sensitivity analysis was performed to address the outcome when the main factors in the economic analysis were changed; this had no significant effect on the conclusions of the study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Planes A, Silsiguen M, Vochelle N. Prevention of venous thromboembolism. In Bergqvist D, Comerota AJ, Nicolaides AN, et al., editors. European Consensus Statement. London: Med Opin Publ Com, 1994: 271–80
Borris LC, Lassen MR, Jensen HP, et al. Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery: clinical and economic considerations. Int J Clin Pharmacol Ther 1994; 32: 262–8
Bergqvist D, Jendteg S, Lindgren B, et al. The economics of general thromboembolic prophylaxis. World J Surg 1988; 12: 349–55
Menzin J, Richter R, Huse D, et al. Prevention of deep-vein thrombosis following total hip replacement surgery with enoxaparin versus unfractionated heparin: a pharmacoeconomic evaluation. Ann Pharmacother 1994; 28: 271–5
O’Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Can Med Assoc J 1994; 150: 1083–90
Danish Enoxaparin Study Group. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 1991; 151: 1621–4
Trowbridge A, Boese CK, Woodruff B, et al. Incidence of posthospitalization proximal deep vein thrombosis after total hip arthroplasty. A pilot study. Clin Orthop 1994; 299: 203–8
Scurr JH, Coleridge-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. BMJ 1988; 297: 28–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borris, L.C., Lassen, M.R. Thromboprophylaxis with Low Molecular Weight Heparin after Major Orthopaedic Surgery is Cost Effective. Drugs 52 (Suppl 7), 42–46 (1996). https://doi.org/10.2165/00003495-199600527-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199600527-00008